JPS52151168A - Heterocyclic compound - Google Patents
Heterocyclic compoundInfo
- Publication number
- JPS52151168A JPS52151168A JP6525277A JP6525277A JPS52151168A JP S52151168 A JPS52151168 A JP S52151168A JP 6525277 A JP6525277 A JP 6525277A JP 6525277 A JP6525277 A JP 6525277A JP S52151168 A JPS52151168 A JP S52151168A
- Authority
- JP
- Japan
- Prior art keywords
- heterocyclic compound
- heterocyclic
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
- C07D233/78—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2287776 | 1976-06-03 | ||
| GB5034076 | 1976-12-02 | ||
| GB1214577 | 1977-03-23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS52151168A true JPS52151168A (en) | 1977-12-15 |
| JPS6222986B2 JPS6222986B2 (cs) | 1987-05-20 |
Family
ID=27256793
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP6525277A Granted JPS52151168A (en) | 1976-06-03 | 1977-06-02 | Heterocyclic compound |
Country Status (12)
| Country | Link |
|---|---|
| JP (1) | JPS52151168A (cs) |
| CA (1) | CA1176261A (cs) |
| CH (3) | CH645631A5 (cs) |
| DE (1) | DE2724948A1 (cs) |
| DK (1) | DK244577A (cs) |
| ES (5) | ES459412A1 (cs) |
| FI (1) | FI71930C (cs) |
| FR (1) | FR2362839A1 (cs) |
| HU (1) | HU183046B (cs) |
| NL (1) | NL7706064A (cs) |
| NZ (1) | NZ184281A (cs) |
| SE (2) | SE446336B (cs) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006527189A (ja) * | 2003-06-06 | 2006-11-30 | アラーガン、インコーポレイテッド | ピペリジニルプロスタグランジンe類似体 |
| JP2011173926A (ja) * | 2003-06-06 | 2011-09-08 | Allergan Inc | ピペリジニルプロスタグランジンe類似体 |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1602188A (en) * | 1977-12-01 | 1981-11-11 | Wellcome Found | Hydantoin derivatives |
| AT372681B (de) * | 1977-09-05 | 1983-11-10 | Wellcome Found | Verfahren zur herstellung von neuen 1,5-disubstituierter hydantoinen |
| JPS5492962A (en) * | 1977-12-01 | 1979-07-23 | Wellcome Found | Thiohydantoin compound |
| DE2963795D1 (en) * | 1978-01-23 | 1982-11-11 | Beecham Group Plc | Hydantoins and thiohydantoins, method for their preparation and pharmaceutical compositions containing them |
| EP0004723A1 (en) * | 1978-03-30 | 1979-10-17 | Beecham Group Plc | Deoxyhydantoins, processes for their preparation and pharmaceutical compositions containing them |
| GB1599740A (en) * | 1978-05-31 | 1981-10-07 | Wellcome Found | Hydantoin derivatives |
| IL57504A0 (en) * | 1978-06-15 | 1979-10-31 | Beecham Group Ltd | Prostagandin analogues,their preparation and pharmaceutical compositions containing |
| CA1122222A (en) * | 1978-06-15 | 1982-04-20 | Frederick Cassidy | Novel 1,2,4-triazolidine-3,5-dione derivatives |
| AU4778279A (en) * | 1978-06-15 | 1979-12-20 | Beecham Group Limited | Prostaglandin analogues |
| EP0006352A1 (en) * | 1978-06-15 | 1980-01-09 | Beecham Group Plc | Hydantoins and thiohydantoins, process for their preparation and pharmaceutical compositions containing them |
| IL59065A0 (en) | 1979-01-18 | 1980-05-30 | Beecham Group Ltd | Hydantoin derivatives,their preparation pharmaceutical compositons containing them |
| GB2050371A (en) * | 1979-05-09 | 1981-01-07 | Wellcome Found | Optically active hydantoin derivatives and pharmaceutical formulations containing them |
| US4684735A (en) * | 1985-07-01 | 1987-08-04 | Stauffer Chemical Company | Promotion of raney nickel hydrogenation catalyst |
| JP3022878U (ja) * | 1995-08-18 | 1996-04-02 | 有限会社春江加工 | ミニディスク用ケース |
| HUP0402486A3 (en) * | 2001-11-30 | 2007-05-02 | Lilly Co Eli | Nitrogen containing heterocyclic compounds as peroxisome proliferator activated receptor agonists, their use and pharmaceutical compositions cointaining them |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1524818A (en) * | 1974-11-29 | 1978-09-13 | Beecham Group Ltd | 12-azaprostaglandins |
-
1977
- 1977-06-02 FI FI771763A patent/FI71930C/fi not_active IP Right Cessation
- 1977-06-02 NZ NZ184281A patent/NZ184281A/xx unknown
- 1977-06-02 SE SE7706428A patent/SE446336B/xx unknown
- 1977-06-02 NL NL7706064A patent/NL7706064A/xx not_active Application Discontinuation
- 1977-06-02 FR FR7716849A patent/FR2362839A1/fr active Granted
- 1977-06-02 CA CA000280455A patent/CA1176261A/en not_active Expired
- 1977-06-02 ES ES459412A patent/ES459412A1/es not_active Expired
- 1977-06-02 DK DK244577A patent/DK244577A/da not_active Application Discontinuation
- 1977-06-02 CH CH679677A patent/CH645631A5/de not_active IP Right Cessation
- 1977-06-02 JP JP6525277A patent/JPS52151168A/ja active Granted
- 1977-06-02 HU HU77WE560A patent/HU183046B/hu unknown
- 1977-06-02 DE DE19772724948 patent/DE2724948A1/de not_active Ceased
-
1978
- 1978-06-01 ES ES470428A patent/ES470428A1/es not_active Expired
-
1979
- 1979-02-28 ES ES478156A patent/ES478156A1/es not_active Expired
- 1979-06-28 ES ES482010A patent/ES482010A1/es not_active Expired
-
1980
- 1980-03-25 ES ES489883A patent/ES8103057A1/es not_active Expired
-
1982
- 1982-05-19 SE SE8203161A patent/SE8203161L/sv not_active Application Discontinuation
-
1984
- 1984-02-07 CH CH57784A patent/CH646426A5/de not_active IP Right Cessation
- 1984-02-07 CH CH576/84A patent/CH647511A5/de not_active IP Right Cessation
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006527189A (ja) * | 2003-06-06 | 2006-11-30 | アラーガン、インコーポレイテッド | ピペリジニルプロスタグランジンe類似体 |
| JP2011173926A (ja) * | 2003-06-06 | 2011-09-08 | Allergan Inc | ピペリジニルプロスタグランジンe類似体 |
Also Published As
| Publication number | Publication date |
|---|---|
| NL7706064A (nl) | 1977-12-06 |
| HU183046B (en) | 1984-04-28 |
| ES489883A0 (es) | 1981-02-16 |
| ES459412A1 (es) | 1978-11-01 |
| FR2362839A1 (fr) | 1978-03-24 |
| FI71930B (fi) | 1986-11-28 |
| ES478156A1 (es) | 1979-11-01 |
| SE446336B (sv) | 1986-09-01 |
| CH646426A5 (en) | 1984-11-30 |
| CH647511A5 (en) | 1985-01-31 |
| JPS6222986B2 (cs) | 1987-05-20 |
| NZ184281A (en) | 1980-04-28 |
| SE8203161L (sv) | 1982-05-19 |
| ES482010A1 (es) | 1980-08-16 |
| DK244577A (da) | 1977-12-04 |
| FI71930C (fi) | 1987-03-09 |
| CA1176261A (en) | 1984-10-16 |
| DE2724948A1 (de) | 1977-12-15 |
| FI771763A7 (fi) | 1977-12-04 |
| FR2362839B1 (cs) | 1980-02-01 |
| SE7706428L (sv) | 1977-12-04 |
| ES8103057A1 (es) | 1981-02-16 |
| ES470428A1 (es) | 1979-09-01 |
| CH645631A5 (en) | 1984-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EG13149A (en) | Heterocyclic compounds | |
| JPS52151348A (en) | Compound | |
| ZA771381B (en) | Heterocyclic compounds | |
| JPS5363424A (en) | Bitumious compound | |
| JPS52125197A (en) | Transshexahydroopyridooindole compound | |
| ZA771963B (en) | Heterocyclic compounds | |
| JPS5359686A (en) | Compound | |
| JPS52136170A (en) | Heterocyclic compound | |
| JPS5295689A (en) | Betaalactummcontaining compound | |
| JPS5325537A (en) | Compound | |
| JPS55127390A (en) | Aryltrifluoroethylamine compound | |
| JPS5353618A (en) | Nnsubstituted biscarbamoylsulfide compound | |
| ZA774154B (en) | Heterocyclic compounds | |
| JPS5293772A (en) | Indolinospiropyran compound | |
| JPS5323995A (en) | Antiibacterial compound | |
| ZA777536B (en) | Heterocyclic compounds | |
| JPS5321222A (en) | Bissbenzoxazolyl compound | |
| JPS5337653A (en) | 111deoxyy111oxaprostaglandin compound | |
| JPS52156899A (en) | Compound | |
| JPS5315371A (en) | Heterocyclic compound | |
| JPS5315383A (en) | Heterocyclic compound | |
| JPS5353692A (en) | Antiiworm compound | |
| JPS5315370A (en) | Heterocyclic compound | |
| JPS55102588A (en) | Tetraselenapentalene compound | |
| ZA776857B (en) | Heterocyclic compounds |